Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             132 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bispecific antibody induces efficient killing of tumor cells Zeidler, R.
 1997
 33 S5 p. S43-
1 p.
 artikel
2 A clinical role for stem cell factor (SCF) in cancer patient management Crowther, D
 1997
 33 S5 p. S11-
1 p.
 artikel
3 Activation-induced cell death of T cells is prevented by coculture with dendritic cells Daniel, P.T.
 1997
 33 S5 p. S34-
1 p.
 artikel
4 Activation of immune effector cell cytolytic activity by the alkaloid derivative Ukrain (NSC631570) Liepins, A.
 1997
 33 S5 p. S26-
1 p.
 artikel
5 Active cell death in ovarian carcinoma cells can be induced with benzamide riboside, an inhibitor of the guanosine pathway Grusch,
 1997
 33 S5 p. S35-
1 p.
 artikel
6 Adoptive immunotherapy (TIL + IL-2) after metastasectomy in 34 patients with melanoma, colorectal and renal carcinoma Ridolfi, R
 1997
 33 S5 p. S28-
1 p.
 artikel
7 Angiogenesis-directed incorporation of genetically-modified endothelial cells as systemic anti-tumor therapy Zwiebel, James A.
 1997
 33 S5 p. S54-
1 p.
 artikel
8 Angio-genesis-inhibition and intra-arterial chemotherapy — A new modality treatment for advanced and metastatic pancreatic carcinoma Müller, H.
 1997
 33 S5 p. S48-
1 p.
 artikel
9 A novel herpes vector for the high efficiency transduction of primary hematopoietic cells Dilloo, D.
 1997
 33 S5 p. S51-
1 p.
 artikel
10 Antibody mediated therapy of minmal residual leukemia: Use of humanized monoclonal antibodies and targeted alpha particles Scheinberg, David A.
 1997
 33 S5 p. S39-
1 p.
 artikel
11 Antimetastatic effect of a standardized mistletoe preparation on B16 melanoma cells in mice Mengs, Ulrich
 1997
 33 S5 p. S48-
1 p.
 artikel
12 Antisense and dominant negative constructs as selective inhibitors of PKC isozymes Grunicke, H.
 1997
 33 S5 p. S52-
1 p.
 artikel
13 Antitumor effects of the combination immunotherapy with interleukin-12 and tumor nectosis factor α in mice Lasek, W.
 1997
 33 S5 p. S14-
1 p.
 artikel
14 Apoptosis and cytokine release are biological responses mediated by recombinant mistletoe lectin in vitro Moeckel, B.
 1997
 33 S5 p. S35-
1 p.
 artikel
15 Apoptosis in tumor cells Rapp, Ulf R.
 1997
 33 S5 p. S33-
1 p.
 artikel
16 Apoptosis of Ovarian carcinoma cells (N1) by TNF and it's possible targets Fuhrmann, G.
 1997
 33 S5 p. S34-
1 p.
 artikel
17 Aqueous mistletoe extracts and vesicles induce T-cell proliferation of sensitized lymphocytes in patients treated with mistletoe extracts Fischer, S.
 1997
 33 S5 p. S23-
1 p.
 artikel
18 Biochemical mechanisms realization of antitumor activity of Ukrain Nefyodov, L.
 1997
 33 S5 p. S27-
1 p.
 artikel
19 Bispecific antibody modified tumor veaccine for human T cell stimulation Schirrmacher, Volker
 1997
 33 S5 p. S21-
1 p.
 artikel
20 Cellular therapy of renal cell carcinoma past, present, future Figlin, Robert
 1997
 33 S5 p. S19-
1 p.
 artikel
21 Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage HIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment Mantovani, G.
 1997
 33 S5 p. S26-
1 p.
 artikel
22 Cloning of the active principle of mistletoe: The contribution of mistletoe lectin single chains to biological functions Langer, M.
 1997
 33 S5 p. S24-
1 p.
 artikel
23 Combined treatment modality of esophageal cancer: Radiation therapy (RT) with photodynamic therapy (PDT) Schaffer, M.
 1997
 33 S5 p. S29-
1 p.
 artikel
24 Comparative studying of radiomodifying activity of immunomodulator Ukrain and other cytostatics Boyko, V.
 1997
 33 S5 p. S22-
1 p.
 artikel
25 Costimulation with agonistic anti-CD28 antibodies prevents T cell apoptosis and is required for efficient immunotherapy with CD3x19 bispecific antibodies in B cell lymphoma Daniel, P.T.
 1997
 33 S5 p. S42-
1 p.
 artikel
26 Costimulatory signals through interaction of B7.1 and CD28 prevent “veto” death of cytotoxic T cells during tumor target cell lysis Daniel, P.T.
 1997
 33 S5 p. S34-
1 p.
 artikel
27 Critical overview concerning new agents that block invasion/metastasis Burger, Max M.
 1997
 33 S5 p. S47-
1 p.
 artikel
28 Cytokine gene transcription and growth inhibition of SIV (Simian immunodeficiency virus) — associated B — NHL in macaques Buske, C.
 1997
 33 S5 p. S14-
1 p.
 artikel
29 Cytokine gene transfer studies in a murine B cell lymphoma model Strehl, J.
 1997
 33 S5 p. S56-
1 p.
 artikel
30 Cytotoxicity of mistletoe extracts and mistletoe lectins towards tumor cells due to the induction of programmed cell death (apoptosis) Fischer, S.
 1997
 33 S5 p. S34-
1 p.
 artikel
31 Cytotoxic T-cells with grafted, tumor-specific recognition functions Groner, Bernd
 1997
 33 S5 p. S20-
1 p.
 artikel
32 Dendritic cell-based immunotherapy of cancer from preclinical studies to clinical applications Zitvogel,
 1997
 33 S5 p. S21-
1 p.
 artikel
33 Dendritic cell-based therapy for cancer Tüting, Thomas
 1997
 33 S5 p. S21-
1 p.
 artikel
34 Dendritic cells for autologous tumor vaccination in chronic myeloid leukemia Westermann, J.
 1997
 33 S5 p. S30-
1 p.
 artikel
35 Design and evaluation of a novel friend virus retroviral vector for gene therapy Cohen-Haguenauer, O.
 1997
 33 S5 p. S51-
1 p.
 artikel
36 Development of a new recombinant anti-CD30 immunotoxin (CD30L-ETA') for the treatment of Hodgkin's lymphoma Barth, S.
 1997
 33 S5 p. S22-
1 p.
 artikel
37 Development of ribozymes and antisense oligonucleotides targeting genes involved in drug resistance and pathogenesis of B-cell lymphoma Bertram, J.
 1997
 33 S5 p. S55-
1 p.
 artikel
38 Does the activity of the Th2 and the Ts subset, in contrast to that of the Th1 and the Tc subset critically depend on the influx of extracellular Ca++ through the L-type Ca++-channels? Leskovar, P.
 1997
 33 S5 p. S24-
1 p.
 artikel
39 Effective IL-2 therapy Den Otter, Willem
 1997
 33 S5 p. S15-
1 p.
 artikel
40 Effect of bleomycin and asparaginase on leukotriene production in vitro and in vivo Geuenich, Susanne
 1997
 33 S5 p. S23-
1 p.
 artikel
41 Effect of PEG-rHu MGDF in the induction treatment of acute myeloid leukemia Hoelzer, D.
 1997
 33 S5 p. S5-
1 p.
 artikel
42 Efficacy of antitumor drug Ukrain in treatment of bladder cancer Uglyanitsa, K.
 1997
 33 S5 p. S30-
1 p.
 artikel
43 Efficient and sustained gene transfer in terminally differentiated cells with a lentiviral vector Blömer, Ulrike
 1997
 33 S5 p. S51-
1 p.
 artikel
44 Enhancement of radiosensitivity by beta-interferon in cell culture MCF 7 and ZMK 1 Busch, M.
 1997
 33 S5 p. S13-
1 p.
 artikel
45 Expression of B7.1 in squamous cell carcinoma of the head and neck enhances proliferation and cytotoxicity of allogeneic and autologous lymphocytes Lang, S.
 1997
 33 S5 p. S55-
1 p.
 artikel
46 Expression patterns and functional activity of the human 14C5 cell substrate adhesion molecule Coene, E.
 1997
 33 S5 p. S42-
1 p.
 artikel
47 FLT3 ligand: A new regulator of hematopoietic stem cells Lyman, Stewart D.
 1997
 33 S5 p. S6-
1 p.
 artikel
48 From diagnosis to therapy: New approaches in detection and characterisation of circulating tumor cells Austrup, F.
 1997
 33 S5 p. S48-
1 p.
 artikel
49 Gene ad cellular therapy at novartis pharma Burger, K.J.
 1997
 33 S5 p. S51-
1 p.
 artikel
50 Generation and immortalisation of a tumor specific cytotoxic T cell line from a healthy donor Pecher, G.
 1997
 33 S5 p. S27-
1 p.
 artikel
51 Generation of anti-tumor activity by bispecific antibodies in non-Hodgkin lymphoma: In vitro inhibition of autologous haematopoiesis Brandt, M.
 1997
 33 S5 p. S41-
1 p.
 artikel
52 Genetically-engineered allogeneic renal cell carcinoma vaccines Schendel, D.J.
 1997
 33 S5 p. S20-
1 p.
 artikel
53 Glycotopes of the Thomsen-Friedenreich type as promising targets for biological tumour therapies Cao, Y.
 1997
 33 S5 p. S41-
1 p.
 artikel
54 Hematopoietic growth factors in the treatment of acute leukemias the development of biologically defined concepts Hiddemann, W.
 1997
 33 S5 p. S11-
1 p.
 artikel
55 Hemopoietic growth factor regulation in malignant hemopoiesis Hogge, Donna
 1997
 33 S5 p. S5-
1 p.
 artikel
56 Idiotype vaccination for patients with non-Hodgkin's lymphoma Caspar, Clemens B.
 1997
 33 S5 p. S19-
1 p.
 artikel
57 IFN-α therapy of renal cell carcinoma: Questions regarding cellular immunotherapy Characiejus, D.
 1997
 33 S5 p. S14-
1 p.
 artikel
58 Immune regulation via non-immunological receptors on immunocompetent cells: Strong immunosuppression, induced by adenosine and epinephrine Leskovar, P.
 1997
 33 S5 p. S25-
1 p.
 artikel
59 Immuno-gene therapy of human melanoma phase I/II clinical trial Mackiewicz, Andrzei
 1997
 33 S5 p. S20-
1 p.
 artikel
60 Immunological responses to CA125 induced by the anti-idiotypic antibody MAb ACA125 — Results of a clinical phase Ib study Wagner, U.
 1997
 33 S5 p. S43-
1 p.
 artikel
61 Immunomodulation by histamine, serotonine and dopamine Leskovar, P.
 1997
 33 S5 p. S25-
1 p.
 artikel
62 Immunotherapy of breast cancer with an anti-idiotypic antibody mimicking a human cell substrate adhesion molecule in an in-vivo model Köhler, S.
 1997
 33 S5 p. S43-
1 p.
 artikel
63 Increasing interferons (IFNs) effectiveness through augmentation of gene expression Borden, Ernest C.
 1997
 33 S5 p. S11-
1 p.
 artikel
64 Influence of some intracellular cAMP-level increasing substances (a) on resting and (b) on proliferating immunocytes Leskovar, P.
 1997
 33 S5 p. S25-
1 p.
 artikel
65 Inhibitory effect of prostaglandin (PG) D2, PGJ2 and Δ12-PGJ2 on proliferation of cells involved in host defense Haberl, C.
 1997
 33 S5 p. S24-
1 p.
 artikel
66 In-situ cytokine therapy by immunokines: Induction of T-cell mediated antitumor immunity Becker, JC
 1997
 33 S5 p. S19-
1 p.
 artikel
67 Interferon in the treatment of polycythemia vera Chen, Xiao
 1997
 33 S5 p. S7-
1 p.
 artikel
68 Interleukin 12: Generation of a cellular immune response against autologous single tumour cells of GIT-carcinoma Stroehlein, M.A.
 1997
 33 S5 p. S29-
1 p.
 artikel
69 Intracranial murine glioma 261 model to study the antitumor activity of autologous cancer vaccines, producing various cytokines Horváth, L.
 1997
 33 S5 p. S24-
1 p.
 artikel
70 Intraperitoneal hrec TNF α (Tumor Necrosis Factor α) administration in patients with hydroperotoneum in the course of an advanced neoplastic disease Braczkowski, R.
 1997
 33 S5 p. S13-
1 p.
 artikel
71 Intraperitoneal therapy with interleukin-2 (nIL-2) in patients with ovarian carcinoma — Pre-clinical and clinical results Schröder, W
 1997
 33 S5 p. S29-
1 p.
 artikel
72 Intratumoral injection of a Viscum album L. preparation in a case of unresectable, occlusive carcinoma of the esophagus Büssing, A.
 1997
 33 S5 p. S23-
1 p.
 artikel
73 Introduction Zwierzina, Heinz
 1997
 33 S5 p. S1-
1 p.
 artikel
74 Introduction of novel T-cell receptors into T cells for adoptive immunotherapy Dull, T.
 1997
 33 S5 p. S52-
1 p.
 artikel
75 In vitro effects of interleukins 7 and 12 on the activity of natural killer cells Konjevic, G.
 1997
 33 S5 p. S14-
1 p.
 artikel
76 Irregular production of cytokines in hairy leukemia: Effects of IFN-α Schwarzmeier, J.D.
 1997
 33 S5 p. S6-
1 p.
 artikel
77 Is Fas Ligand expression by glioma a major mechanism of inactivation of tumor infiltrating lymphocytes? Dietrich, P.-Y-
 1997
 33 S5 p. S33-
1 p.
 artikel
78 ISIS 3521/CGP 64128A- antisense to protein kinase C-alpha Dorr, F.A.
 1997
 33 S5 p. S52-
1 p.
 artikel
79 Isolation and characterization of an Ewing's tumor specific antigen recognized by a mAb Borowski, A.
 1997
 33 S5 p. S41-
1 p.
 artikel
80 Leucine zipper, nuclear targeting and P130 interaction motifs in the epidermal growth factor precursor: The nucleocrine connection further unveiled Radulescu, Razvan T.
 1997
 33 S5 p. S15-
1 p.
 artikel
81 Liposome-mediated gene transfer into human dendritic cells Pecher, G.
 1997
 33 S5 p. S27-
1 p.
 artikel
82 Lysis of human carcinoma cells by NK cells correlates with HSP72 cell surface expression Botzler, C.
 1997
 33 S5 p. S22-
1 p.
 artikel
83 MAb 14C5 against a human cell substrate adhesion molecule for inhibition of tumor growth in-vivo Giffels, P.
 1997
 33 S5 p. S42-
1 p.
 artikel
84 Mechanisms of stem cell mobilization Fibbe, WE
 1997
 33 S5 p. S5-
1 p.
 artikel
85 Molecular functions of the tumor progession protein CD44 Ponta, Helmut
 1997
 33 S5 p. S47-
1 p.
 artikel
86 Molecular strategies to generate tumor vaccines for non-Hodgkin's lymphoma Hallek, M.
 1997
 33 S5 p. S52-
1 p.
 artikel
87 Mouse IL-2-transfected plasmocytoma cells in a therapy of allogeneic tumor-bearing mice Kuśnierczyk, Halina
 1997
 33 S5 p. S55-
1 p.
 artikel
88 Mucin gene (MUC1) transfected dendritic cells as tumor vaccine in patients with breast or pancreatic cancer Pecher, G.
 1997
 33 S5 p. S28-
1 p.
 artikel
89 Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy Savas, B.
 1997
 33 S5 p. S28-
1 p.
 artikel
90 Mutant E-cadherin as a new target for diagnosis and therapy of diffuse-type gastric cancer Becker, Karl-Friedrich
 1997
 33 S5 p. S41-
1 p.
 artikel
91 Negative control of haemopoiesis Testa, N.G.
 1997
 33 S5 p. S12-
1 p.
 artikel
92 Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results Mantovani, G.
 1997
 33 S5 p. S26-
1 p.
 artikel
93 Novel antibody-based fusion proteins in cancer treatment Begent, RHJ
 1997
 33 S5 p. S39-
1 p.
 artikel
94 ONYX-015: An adenovirus attenuated in the E1B-55KD gene selectively replicates in, and causes lysis of, P53- tumor cells Kirn, D.
 1997
 33 S5 p. S53-
1 p.
 artikel
95 Overexpression of erbB2/neu oncoprotein and Fas ligand death signals in breast cancer Venanzi, F.M.
 1997
 33 S5 p. S36-
1 p.
 artikel
96 pBM1.1, a new pET-based vector for high efficiency expression of ETA′ fusion toxins Matthey, B.
 1997
 33 S5 p. S56-
1 p.
 artikel
97 Pilot trial of MDX-H210 and GM-CSF for patients with advanced erbB-2 positive malignancies Posey, J.
 1997
 33 S5 p. S53-
1 p.
 artikel
98 Preliminary results of a phase I trial of antisense to BCL-2 in lymphoma Waters, J.
 1997
 33 S5 p. S54-
1 p.
 artikel
99 Rapid generation of human antibodies against tumour associated antigens Knappik, A.
 1997
 33 S5 p. S43-
1 p.
 artikel
100 Recombinant human erythropoietin-rHuEPO for anemic cancer patients on combination chemotherapy Pavlov, Anatol D.
 1997
 33 S5 p. S15-
1 p.
 artikel
101 Recombinant lectin rML: A novel inducer of cytokines in vitro Schwarz, Tobias
 1997
 33 S5 p. S16-
1 p.
 artikel
102 Reduction of CD3-mediated apoptosis in human T cells by CD28-costimulation: Possible mechanisms Müller, Y.
 1997
 33 S5 p. S35-
1 p.
 artikel
103 Renal cell carcinoma: Adjuvant therapy with a pure cell-lysate autologous tumor vaccine (ATM) Ulbrich, C
 1997
 33 S5 p. S30-
1 p.
 artikel
104 Retinoblastoma protein-derived peptides: Further definition of their antineoplastic properties Radulescu, Razvan T.
 1997
 33 S5 p. S35-
1 p.
 artikel
105 Retrovirus vectors Ostertag, Wolfram
 1997
 33 S5 p. S53-
1 p.
 artikel
106 Review of single agent IDEC-C2B8 safety and efficacy results in low-grade or follicular non-Hodgkin's lymphoma (NHL) White, C.A.
 1997
 33 S5 p. S40-
1 p.
 artikel
107 Stem cell factor (r-metHuSCF) in combination with filgrastim (r-metHuG-CSF) enhances peripheral blood progenitor cell (PBPC) mobilisation following chemotherapy: A randomised study Weaver, A.
 1997
 33 S5 p. S6-
1 p.
 artikel
108 Stimulation of CD 40 up-regulates costimulatory molecules on chronic B-lymphocytic leukemia cells and induces efficient killing of stimulated and not-stimulated B-CLL by cytolytic effector cells Buhamnn, R.
 1997
 33 S5 p. S19-
1 p.
 artikel
109 Study of mechanism of apoptosis induction by Ukrain in vitro Votrin, I.I.
 1997
 33 S5 p. S36-
1 p.
 artikel
110 Successful postsurgical immunotherapy of patients with III–IV stages of cancer Tarasov, V.
 1997
 33 S5 p. S29-
1 p.
 artikel
111 Suicide gene therapy in cancer Mullen, Craig A.
 1997
 33 S5 p. S53-
1 p.
 artikel
112 Suppressor T cell (Ts) and cytotoxic T cell (Tc/CTL): The same cell in two functional states, differing (a) in the activation of PC vs. PI- dependent PLC upon CD3/Ti-ligation, and (b) in the dependence on extracellular Ca++-source? Leskovar, P.
 1997
 33 S5 p. S25-
1 p.
 artikel
113 Synergistic interaction of retinoids and interferons in breast cancer Marth, C.
 1997
 33 S5 p. S15-
1 p.
 artikel
114 T cell regeneration after chemotherapy: Implications for immunotherapy in the setting of minimal residual disease Mackall, Crystal L.
 1997
 33 S5 p. S20-
1 p.
 artikel
115 TGF — β is an inhibitory cytokine for normal and leukemic B — cell precursors Buske, C.
 1997
 33 S5 p. S13-
1 p.
 artikel
116 The chemokines IP-10 and Mig identified as mediators of tumor necrosis in vivo Sgadari, Cecilia
 1997
 33 S5 p. S47-
1 p.
 artikel
117 The combination IFN-α/IL-2 and monoclonal antibody 17-1A induces a marked antibody dependent cellular cytotoxicity (ADCC) against the colorectal tumor cell line HT29 Flieger, D.
 1997
 33 S5 p. S42-
1 p.
 artikel
118 The complex treatment of patients with rectum cancer — A randomised study Bondar, G.
 1997
 33 S5 p. S22-
1 p.
 artikel
119 The effect of human granulocyte and granulocyte macrophage-colony stimulating factors on neutrophil chemiluminesce Aydin, M.
 1997
 33 S5 p. S13-
1 p.
 artikel
120 The impact of intraperitoneal zymosan on early postoperative period in colorectal cancer patients Donina, S.
 1997
 33 S5 p. S23-
1 p.
 artikel
121 The relevance of the BCL-2 gene and Wilm's tumor gene for the long-term prognosis of acute myeloid leukemia Bergmann, L.
 1997
 33 S5 p. S5-
1 p.
 artikel
122 The role of HSP72 in vivo — A SCID mouse model Multhoff, G.
 1997
 33 S5 p. S27-
1 p.
 artikel
123 The role of immunomodulation on anti-tumour activity of hexadecylphosphocholine Safa, O.
 1997
 33 S5 p. S28-
1 p.
 artikel
124 The role of T cells, induction of antineovascular chemokines, and apoptotic factors in the antitumor activity of IL-12/Pulse IL-2 Wiltrout, R.H.
 1997
 33 S5 p. S12-
1 p.
 artikel
125 Transforming growth factors alpha & beta — Positive and negative regulators of epithelial growth Leake, Robin
 1997
 33 S5 p. S11-
1 p.
 artikel
126 Tumor-associated angiogenesis: Pathogenesis and clinical implications Pluda, James M.
 1997
 33 S5 p. S47-
1 p.
 artikel
127 Tumor immunotherapy with bispecific antibodies: from bench- to bedside Jung, Gundram
 1997
 33 S5 p. S39-
1 p.
 artikel
128 Tumor specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transfer Schirrmann, T.
 1997
 33 S5 p. S56-
1 p.
 artikel
129 Ukrain induced bimodal cell death in wild-type and multidrug resistant CEM leukemia cells Liepins, A.
 1997
 33 S5 p. S26-
1 p.
 artikel
130 Up-regulation of surface CD95 following γ-irradiation of p53WILDTYPE tumor cells, but not p53MUTANT or p53(−/−) cells Sheard, Michael
 1997
 33 S5 p. S36-
1 p.
 artikel
131 Virus-free B cell lines expressing mucin (MUC1) gene by transfection with a mini-EBV plasmid Kilger, E.
 1997
 33 S5 p. S55-
1 p.
 artikel
132 ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumour regressions in colorectal tumour xenografts Blakey, D.C.
 1997
 33 S5 p. S39-
1 p.
 artikel
                             132 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland